Sound View Wealth Advisors Group’s Biogen BIIB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
– Sell
-1,164
Closed -$226K – 416
2024
Q3
$226K Buy
+1,164
New +$244K 0.02% 382
2024
Q1
– Sell
-1,188
Closed -$307K – 374
2023
Q4
$307K Buy
1,188
+25
+2% +$6.14K 0.03% 299
2023
Q3
$299K Buy
+1,163
New +$311K 0.04% 286
2023
Q2
– Sell
-987
Closed -$274K – 365
2023
Q1
$274K Sell
987
-201
-17% -$55.6K 0.04% 296
2022
Q4
$307K Buy
+1,188
New +$336K 0.03% 299
2020
Q4
– Sell
-757
Closed -$215K – 256
2020
Q3
$215K Hold
757
– – 0.06% 232
2020
Q2
$203K Buy
+757
New +$228K 0.06% 232

Other funds holding BIIB

Sound View Wealth Advisors Group's BIIB Position: Q4 2024 in Review

Sound View Wealth Advisors Group sold out of Biogen (BIIB) in Q4 2024, closing a stake of 1,164 shares — an estimated $226K sold.

Sound View Wealth Advisors Group first reported a position in BIIB in Q2 2020 and held it in 7 quarters. The position peaked at $307K in Q4 2023. 876 funds tracked by Wall St. Rank hold BIIB as of Q4 2024.

  • Sound View Wealth Advisors Group reported no remaining Biogen position as of Q4 2024 after selling out during the quarter.
  • Sound View Wealth Advisors Group sold 1,164 Biogen shares in Q4 2024, an estimated $226K.
  • Sound View Wealth Advisors Group first reported a position in Biogen in Q2 2020 and held it in 7 quarters.
  • Sound View Wealth Advisors Group's Biogen position peaked at $307K in Q4 2023.
  • 876 funds tracked by Wall St. Rank held Biogen as of Q4 2024.

Based on Sound View Wealth Advisors Group's 13F filing for Q4 2024, filed 7 Feb 2025.